Jamjoom Pharmaceuticals Factory Company (4015.SR)
SAR 157.4
(-0.51%)
SAR 157.4
(-0.51%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.1 Billion SAR | 20.09% |
| 2022 | 916.67 Million SAR | 24.6% |
| 2021 | 735.68 Million SAR | -8.65% |
| 2020 | 805.31 Million SAR | 10.06% |
| 2019 | 731.73 Million SAR | 4.34% |
| 2018 | 701.3 Million SAR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 327.58 Million SAR | -5.25% |
| 2024 Q1 | 385.46 Million SAR | 85.41% |
| 2024 Q2 | 345.73 Million SAR | -10.31% |
| 2023 Q4 | 207.9 Million SAR | -28.95% |
| 2023 FY | 1.1 Billion SAR | 20.09% |
| 2023 Q3 | 292.61 Million SAR | -1.94% |
| 2023 Q2 | 298.39 Million SAR | -1.18% |
| 2023 Q1 | 301.95 Million SAR | 53.4% |
| 2022 Q2 | 238.29 Million SAR | -2.25% |
| 2022 Q1 | 243.78 Million SAR | 15.86% |
| 2022 FY | 916.67 Million SAR | 24.6% |
| 2022 Q4 | 196.83 Million SAR | -17.21% |
| 2022 Q3 | 237.75 Million SAR | -0.23% |
| 2021 FY | 735.68 Million SAR | -8.65% |
| 2021 Q4 | 210.4 Million SAR | 0.0% |
| 2021 Q3 | 210.4 Million SAR | 8.99% |
| 2021 Q2 | 193.05 Million SAR | 22.62% |
| 2021 Q1 | 157.43 Million SAR | 0.0% |
| 2020 FY | 805.31 Million SAR | 10.06% |
| 2019 FY | 731.73 Million SAR | 4.34% |
| 2018 FY | 701.3 Million SAR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Saudi Pharmaceutical Industries and Medical Appliances Corporation | 1.65 Billion SAR | 33.408% |